These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6173237)

  • 1. Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice.
    Ron Y; De Baetselier P; Gordon J; Feldman M; Segal S
    Eur J Immunol; 1981 Dec; 11(12):964-8. PubMed ID: 6173237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice. II. Anti-mu treatment affects the initiation and recruitment of T cells.
    Ron Y; De Baetselier P; Tzehoval E; Gordon J; Feldman M; Segal S
    Eur J Immunol; 1983 Feb; 13(2):167-71. PubMed ID: 6403358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes.
    Ron Y; Sprent J
    J Immunol; 1987 May; 138(9):2848-56. PubMed ID: 2952725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional activities of antibodies against brain-associated T cell antigens. II. Stimulation of T cell-induced B cell proliferation.
    Jones B
    Eur J Immunol; 1982 Jan; 12(1):30-7. PubMed ID: 6800828
    [No Abstract]   [Full Text] [Related]  

  • 5. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes.
    Janeway CA; Ron J; Katz ME
    J Immunol; 1987 Feb; 138(4):1051-5. PubMed ID: 3100626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major histocompatibility complex-restricted and unrestricted T helper cells recognizing minor histocompatibility antigens of B cell surfaces.
    Coutinho A; Augustin AA
    Eur J Immunol; 1980 Jul; 10(7):535-41. PubMed ID: 6157541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T lymphocyte-dependent B lymphocyte proliferative response to antigen. II. Induction of polyclonal B lymphocyte activation of normal B cells and of Lyb-5- B cells from xid mice via recognition of self-IA antigens.
    Tse HY; Kanamori S; Mond JJ
    J Immunol; 1984 Oct; 133(4):1792-800. PubMed ID: 6206138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice.
    Kurt-Jones EA; Liano D; HayGlass KA; Benacerraf B; Sy MS; Abbas AK
    J Immunol; 1988 Jun; 140(11):3773-8. PubMed ID: 2453554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
    Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
    J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo obtained antigen presented by germinal center B cells to T cells in vitro.
    Kosco MH; Szakal AK; Tew JG
    J Immunol; 1988 Jan; 140(2):354-60. PubMed ID: 3257234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones.
    Jones B; Tite JP; Janeway CA
    J Immunol; 1986 Jan; 136(1):348-56. PubMed ID: 2415625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease.
    Schultz KR; Paquet J; Bader S; HayGlass KT
    Bone Marrow Transplant; 1995 Aug; 16(2):289-95. PubMed ID: 7581150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of B cells in the stimulation of syngeneic mixed lymphocyte responses.
    Thorbecke GJ; Chapman-Alexander J; Katz IR; Bienenstock A; Asofsky R
    Behring Inst Mitt; 1983 May; (72):107-16. PubMed ID: 6242330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional differentiation in the genetic control of murine T lymphocyte responses to human fibrinopeptide B.
    Peterson LB; Wilner GD; Thomas DW
    J Immunol; 1983 Feb; 130(2):637-43. PubMed ID: 6217245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell development in B cell-deficient mice. IV. The role of B cells as antigen-presenting cells in vivo.
    Hayglass KT; Naides SJ; Scott CF; Benacerraf B; Sy MS
    J Immunol; 1986 Feb; 136(3):823-9. PubMed ID: 2416835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The requirement for surface Ig signaling as a prerequisite for T cell:B cell interactions. A possible role for desialylation.
    Kearse KP; Cassatt DR; Kaplan AM; Cohen DA
    J Immunol; 1988 Mar; 140(6):1770-8. PubMed ID: 3126236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of a distinctive differentiating antigen of activated mouse T- and B-lymphocytes--AKA-1].
    Nesterenko VG; Novikova TK; Fontalin LN; Vekhnik E; Rubakova EI
    Biull Eksp Biol Med; 1980 Oct; 90(10):449-51. PubMed ID: 6968597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell development in B cell deficient mice. III. Restriction specificity of suppressor T cell factor(s) produced in mice treated chronically with rabbit anti-mouse mu chain antibody.
    HayGlass KT; Naides SJ; Benacerraf B; Sy MS
    J Mol Cell Immunol; 1985; 2(2):107-17. PubMed ID: 2978459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabbit leukocyte surface antigens defined by monoclonal antibodies.
    De Smet W; Vaeck M; Smet E; Brys L; Hamers R
    Eur J Immunol; 1983 Nov; 13(11):919-28. PubMed ID: 6605862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.